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Abstract: Although the health benefits
provided by soy protein are known from
decades, especially in the area of cholesterol
control, non-soy legumes have been only
rarely investigated. This is a pity considering
the environmental relevance of these seeds:
indeed a better knowledge of their beneficial
role in the diet may become an important
tool to promote their consumption. We
summarize here available results either from
animal investigations or human trials in the
area of hypercholesterolemia prevention.
This body of data indicates that a regular
consumption of grain legumes is useful for
maintaining a correct lipid profile.
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Introduction
Many studies have shown that the
consumption of soybean protein is useful for
dyslipidemia prevention (10). This activity
was also strongly validated by the US Food
and Drug Administration (FDA) approval of
the “health claim” on the role of soy protein
in reducing the risk of coronary heart
diseases (FDA, Federal Register 1999: 64,
57699-57733). During the following years,
this prompted some research also on other
legumes that will be briefly described in this
review.
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Animal studies
Whereas the first studies on the potential
hypocholesterolemic effects of soybean
(Glycine max (L.) Merr.) dated back to the
„70s, it was not until the „90s that some
researchers started to dedicate resources and
time to non-soy legumes, stimulated by the
similarities among the sequences of the main
protein fractions in legumes. Most of the
experimentation was performed versus casein
or lactalbumin as control proteins using the
rat model of hypercholesterolemia. Table 1
reports a summary of the results of some of
these investigations, which have involved
numerous legumes (for a complete list see
(2)). All studies reported significant and
generally very large decreases of the lipid
parameters versus the control diet, with the
exception of lentil that was the least
effective. Certainly, these data gave clear
indication that these seeds may be beneficial
for dyslipidemia prevention.
Particular attention was dedicated to lupin
(Lupinus spp.) that, owing to its exceptional
protein content, may be considered a
valuable substitute of soy in food
formulation. In this case, besides the usual
investigations on rats, other animal models
were also applied, such as hamster, pig and
rabbit. Rabbit is a model of the
atherosclerotic plaque, since a small
perivascular injury may induce the
development of a focal plaque at both
common carotid arteries. After recovery
from surgery, animals were fed cholesterol-
rich diets containing as casein (control) or a
protein isolate from white lupin (treatment)
for 90 days (9). Cryosection analyses of the
carotids indicated a significant reduction in
focal lesion progression in the lupin vs. the
casein group (-37.4%). Therefore, lupin
protein not only reduces cholesterolemia, but
also exerts a protective activity against
atherosclerosis progression. A study on
hamster has instead shown that a lupin diet
reduces the level of liver steatosis
(accumulation of fat in the liver) (6).
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Grain legume Tested ingredients
Duration
(days)
Total 
cholesterol 
change 
vs. control 
(%)
VLD-C + LDL-C 
or non-HDL-C 
change 
vs. control 
(%)
Butter bean Whole cooked flour 56 -24.0 -38.8
Chickpea Cooked flour 16 -34.1 -43.2
Common bean Whole cooked flour 56 -36.3 -53.0
Cowpea Cooked flour 28 -48.5 -54.2
Faba bean Whole flour 14 -36.8 -56.3
Lentil Cooked flour 56 -6.7 -32.2
Narrow-leafed lupin Protein isolate 28 -55.3 -61.1
Pea Protein isolate 28 -51.6 -58.1
White lupin Protein isolate 21 -22.7 -30.2
Table 1. Effects of grain legumes on lipid metabolism evaluated in the hyperlipidemic rat   
model (2)
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Human studies
The results on the clinical studies on non-
soy legumes are analyzed in a few reviews (1,
4, 5) that give clear indication that a diet rich
in these seeds is useful to decrease total
cholesterol and low density lipoprotein
cholesterol (LDL-C). We have recently
published another very comprehensive
review (2), whose relevant data are
summarized here.
Up to now 20 papers dealing with non-soy
legumes and cholesterol have been published
for a total of 22 different trial arms. These
studies may be classified into four groups: 1)
twelve unblind studies on whole seeds; 2)
one unblind study on a model beverage from
white lupin (L. albus L.) seed; 3) two blind
studies (three arms) on model foods
containing whole kernel flours; 4) five blind
studies (six arms) on purified fiber or
proteins. Considering gender, twelve studies
were on both genders, ten on males alone,
and, surprisingly, none on females alone. All
controlled studies were randomized, about
one half had a parallel design, whereas the
other had a crossover design. The durations
span from 3 weeks to one year, but a 4-
weeks duration is prevalent.
The quantity of legumes consumed daily in
the studies of Group 1 varied as well as the
number of servings per week, which spanned
from 4 to 7. Most of them showed
significant decreases in total cholesterol
(from -8 mg dl-1 to -56 mg dl-1) and LDL-C
(from -7 mg dl-1 to -51 mg dl-1) (2). Group 2
comprises only an uncontrolled 3-months
study evaluating a daily intake of 500 ml of a
model lupin drink on smokers. Significant
decreases in total and LDL-C were observed
in respect to the stabilized lipid values during
the previous diet. Group 3 includes two
blind studies on model foods containing
whole kernel flour. The former, on broad
bean (Vicia faba L.) flour mixed to smashed
potato, reports segregated results for
normocholesterolemic patients (mean initial
cholesterol equal to 200 mg dl-1) and
moderate hypercholesterolemic (mean initial
cholesterol equal to 240 mg dl-1). Both
groups of patients showed decreases of total
and LDL-C that were higher in the
hypercholesterolemic group. On the
contrary, no significant changes were
observed in the latter study, based on
normolipidemic subjects who consumed
bread, biscuits and pasta added with lupin
flour.
With the exception of a paper on a pea
(Pisum sativum L.) protein isolate which was
practically inactive, all studies of Group 4 are
on narrow-leafed lupin (L. angustifolius L.).
The ingredients (fiber or protein isolate)
were included in different kinds of foods.
The kernel fiber, added in breads, muffins,
and other foods, produced small, but
significant decreases of total and LDL-C (7).
Instead, lupin protein (25 g) incorporated
into a lupin drink did not change the lipid
profile in a statistically significant way versus
the control. Two studies were based on
dietary bars containing either the lupin
protein isolate or casein (control bar). In the
former comparable decreases of the lipid
parameters were observed either in the
treatment or in the control. This was
possibly due to the lack of a run-in period
aimed to stabilize the lipid parameters before
the intervention, which in our experience is
crucially important in dietary studies. The
latter study (11) on similar bars, in which the
run-in period was correctly performed, gave
instead better results. In spite of their
unsatisfactory sensory properties, the bars
containing lupin protein produced a
significant decrease of total cholesterol
(-11.6 mg dl-1, -4.2%), whereas no plasma
cholesterol changes were observed in the
control group. Finally, very interesting results
were obtained in a very recent study (3),
where the patients received a portfolio of
different lupin food items, very similar to
normal foods: in fact, statistically decreases
of both total cholesterol (-11.0 mg dl-1,
4.4%) and LDL-C (-6.0 mg dl-1, 3.6%) were
observed. Possibly, the effectiveness of this
study may be explained with the improved
compliance consequent to the varied
portfolio of products that the subjects could
easily include in their daily diet.
Conclusions
Available animal and human
experimentation clearly indicates that
legumes are useful in high cholesterol
prevention. Different seed components may
be responsible of this activity: certainly the
fiber, but also the protein or, better, specific
peptides derived from the proteins that are
able to interfere with cholesterol metabolism
in hepatic cells (8). It would thus be very
advisable to increase the daily consumption
of these seeds: to achieve this objective, it
would be useful to have an easier access to
different food items based on legumes, such
as in the current market of soy foods.
